Designing antimicrobial peptides: form follows function
CD Fjell, JA Hiss, REW Hancock… - Nature reviews Drug …, 2012 - nature.com
Multidrug-resistant bacteria are a severe threat to public health. Conventional antibiotics are
becoming increasingly ineffective as a result of resistance, and it is imperative to find new …
becoming increasingly ineffective as a result of resistance, and it is imperative to find new …
Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review
P Csermely, T Korcsmáros, HJM Kiss, G London… - Pharmacology & …, 2013 - Elsevier
Despite considerable progress in genome-and proteome-based high-throughput screening
methods and in rational drug design, the increase in approved drugs in the past decade did …
methods and in rational drug design, the increase in approved drugs in the past decade did …
ChemoPy: freely available python package for computational biology and chemoinformatics
Motivation: Molecular representation for small molecules has been routinely used in
QSAR/SAR, virtual screening, database search, ranking, drug ADME/T prediction and other …
QSAR/SAR, virtual screening, database search, ranking, drug ADME/T prediction and other …
Characterization of structure–antioxidant activity relationship of peptides in free radical systems using QSAR models: Key sequence positions and their amino acid …
YW Li, B Li - Journal of Theoretical Biology, 2013 - Elsevier
Antioxidative peptides have attracted increasing attention from researchers because of their
antioxidant properties as natural materials in functional food and for applications in …
antioxidant properties as natural materials in functional food and for applications in …
QSPR/QSAR: State-of-art, weirdness, the future
AA Toropov, AP Toropova - Molecules, 2020 - mdpi.com
Ability of quantitative structure–property/activity relationships (QSPRs/QSARs) to serve for
epistemological processes in natural sciences is discussed. Some weirdness of …
epistemological processes in natural sciences is discussed. Some weirdness of …
In-Silico Approaches to Multi-target Drug Discovery: Computer Aided Multi-target Drug Design, Multi-target Virtual Screening
Multi-target drugs against selective multiple targets improve therapeutic efficacy, safety and
resistance profiles by collective regulations of a primary therapeutic target together with …
resistance profiles by collective regulations of a primary therapeutic target together with …
Computer aided drug design for multi-target drug design: SAR/QSAR, molecular docking and pharmacophore methods
A Abdolmaleki, JB Ghasemi, F Ghasemi - Current drug targets, 2017 - ingentaconnect.com
Multi-target drugs against particular multiple targets get better protection, resistance profiles
and curative influence by cooperative rules of a key beneficial target with resistance …
and curative influence by cooperative rules of a key beneficial target with resistance …
Design novel dual agonists for treating type-2 diabetes by targeting peroxisome proliferator-activated receptors with core hopping approach
Y Ma, SQ Wang, WR Xu, RL Wang, KC Chou - PLoS One, 2012 - journals.plos.org
Owing to their unique functions in regulating glucose, lipid and cholesterol metabolism,
PPARs (peroxisome proliferator-activated receptors) have drawn special attention for …
PPARs (peroxisome proliferator-activated receptors) have drawn special attention for …
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species
FJ Prado-Prado, X García-Mera… - Bioorganic & medicinal …, 2010 - Elsevier
There are many of pathogen parasite species with different susceptibility profile to
antiparasitic drugs. Unfortunately, almost QSAR models predict the biological activity of …
antiparasitic drugs. Unfortunately, almost QSAR models predict the biological activity of …
Cannabinoid receptor subtype 2 (CB2R) in a multitarget approach: perspective of an innovative strategy in cancer and neurodegeneration
GF Mangiatordi, F Intranuovo, P Delre… - Journal of Medicinal …, 2020 - ACS Publications
The cannabinoid receptor subtype 2 (CB2R) represents an interesting and new therapeutic
target for its involvement in the first steps of neurodegeneration as well as in cancer onset …
target for its involvement in the first steps of neurodegeneration as well as in cancer onset …